Evidence map›Paper›PMID 38332589›Full record

ArticleActa oncologica (Stockholm, Sweden)2024

Childhood cancer incidence and survival in the Faroe Islands, 1960 to 2019.

Marnar Fríðheim Kristiansen, Elmar Ósá, Lisa Lyngsie Hjalgrim, Bjarni Á Steig, Guðrið Andórsdóttir, Marin Strøm, Maria Skaalum Petersen

Abstract read
In one paragraph

Article in Acta oncologica (Stockholm, Sweden), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marnar Fríðheim KristiansenMedical Department, National Hospital of the Faroe Islands, J.C. Svabosgøta 41-49, Tórshavn, Faroe Islands; Genetic Biobank of the Faroe Islands, Eirargarður 2, Tórshavn, Faroe Islands; Centre of Health Sciences, University of the Faroe Islands, Vestara Bryggja 15, Tórshavn, Faroe Islands. marfr@ls.fo.
Elmar ÓsáMedical Department, National Hospital of the Faroe Islands, J.C. Svabosgøta 41-49, Tórshavn, Faroe Islands.
Lisa Lyngsie HjalgrimDepartment of Paediatrics and Adolescent Medicine, Juliane Marie Centre, Blegdamsvej 9, Copenhagen, Denmark.
Bjarni Á SteigMedical Department, National Hospital of the Faroe Islands, J.C. Svabosgøta 41-49, Tórshavn, Faroe Islands; Genetic Biobank of the Faroe Islands, Eirargarður 2, Tórshavn, Faroe Islands.
Guðrið AndórsdóttirGenetic Biobank of the Faroe Islands, Eirargarður 2, Tórshavn, Faroe Islands.
Marin StrømCentre of Health Sciences, University of the Faroe Islands, Vestara Bryggja 15, Tórshavn, Faroe Islands; Department of Epidemiology Research, Statens Serum Institut, Artillerivej 5, Copenhagen S, Denmark.
Maria Skaalum PetersenCentre of Health Sciences, University of the Faroe Islands, Vestara Bryggja 15, Tórshavn, Faroe Islands; Department of Occupational Medicine and Public Health, The Faroese Hospital System, Sigmundargøta 5, Tórshavn, Faroe Islands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThis study is the first report regarding childhood cancer in the Faroe Islands and describes the incidence and survival of childhood cancer over the last 60 years in the Faroe Islands. MATERIAL AND

methodsWe included all Faroese children registered with a cancer diagnosis up to the age of 19 years in the Faroese Cancer Registry from 1960 to 2019 and in the Danish Childhood Cancer Registry from 1985 to 2019 in this study. We report the number of incident cancers classified according to the 12 main diagnostic groups in the International Classification of Childhood Cancer, third edition (ICCC-3), but due to small numbers some groups have been combined in the results shown. We report age-standardized incidence rates (world standard population) (ASIR). We also show all-cause survival by incidence stratified by 20-year periods.

resultsThere were 114 childhood cancers in the Faroe Islands from 1960 to 2019, corresponding to an ASIR of 13.0 per 100,000 person-years. The most common cancer groups in Faroese children were brain and spinal tumors, followed by leukemias and lymphomas. All-cause survival improved for children diagnosed over time, with a 5-year survival of 43.5% for those diagnosed from 1960 to 1979 and 85.6% for children diagnosed from 2000 to 2019.

conclusionChildhood cancer in the Faroes was slightly rarer than in most other high-income countries. Brain and spinal tumors were the most common cancer group in Faroese children. Survival for Faroese children with cancer has improved substantially in the study period.

Indexed as

Central Nervous System NeoplasmsNeoplasmsSpinal NeoplasmsAdultChildDenmarkHumansIncidenceRegistriesYoung Adult

Identifiers

PMID38332589
PMCPMC11332490

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.